Sfoglia per Rivista HEMATOLOGY JOURNAL
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma
2004-01-01 Palumbo A; Bertola A; Falco P; Rosato R; Cavallo F; Giaccone L; Bringhen S; Musto P; Pregno P; Caravita T; Ciccone G; Boccadoro M
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma.
2004-01-01 Palumbo A; Bertola A; Falco P; Rosato R; Cavallo F; Giaccone L; Bringhen S; Musto P; Pregno P; Caravita T; Ciccone G; Boccadoro M.
Hereditary haemochromatosis
2002-01-01 Camaschella C; De Gobbi M; Roetto A
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors.
2002-01-01 BONATI A.; LUNGHI P.; GAMMAITONI L.; PINELLI S.; RIDOLO E.; DALL'AGLIO P.P.; V. PIACIBELLO; AGLIETTA M.
Myeloma management guidelines: a coMyeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation.
2003-01-01 DURIE BG ;KYLE RA ;BELCH A ;BENSINGER W ;BLADE J ;BOCCADORO M ;CHILD JA ;COMENZO R ;DJULBEGOVIC B ;FANTL D ;GAHRTON G ;HAROUSSEAU JL ;HUNGRIA V ;JOSHUA D ;LUDWIG H ;MEHTA J ;MORALES AR ;MORGAN G ;NOUEL A ;OKEN M ;POWLES R ;ROODMAN D ;SAN MIGUEL J ;SHIMIZU
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
2003-01-01 DURIE BG; KYLE RA; BELCH A; BENSINGER W; BLADE J; BOCCADORO M; CHILD JA; COMENZO R; DJULBEGOVIC B; FANTL D; GAHRTON G; HAROUSSEAU JL; HUNGRIA V; JOSHUA D; LUDWIG H; MEHTA J; MORALES AR; MORGAN G; NOUEL A; OKEN M; POWLES R; ROODMAN D; SAN MIGUEL J; SHIMIZU K; SINGHAL S; SIROHI B; SONNEVELD P; TRICOT G; VAN NESS B; SCIENTIFIC ADVISORS OF THE INTERNATIONAL MYELOMA FOUNDATION.
Naturally-occurring anti-G-CSF antibodies produced by human cord blood B-cell lines infected with Epstein-Barr virus
2001-01-01 Revoltella RP; Laricchia Robbio L; Moscato S; Vinante F; Fasciani A; Liberati AM; Reato G; Foa R
Simultaneous screening of known HFE and TFR2 mutations in blood donors selected for increaesd serum iron parameters.
2002-01-01 M De Gobbi; F Daraio; A Roetto; F Alberti; S. Bosio; MR Barilaro; C Camaschella
Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma
2004-01-01 Falco P; Bertola A; Bringhen S; Cavallo F; Boccadoro M; Palumbo A
The natural history of hemochromatosis type 2.
2001-01-01 De Gobbi M; Roetto A; Piperno A; Papanikolau G; Loukopoulos D; Lockitch G; Girelli P; Gasparini P; Cox T; Cazzola M; Camaschella C
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma | 2004 | Palumbo A; Bertola A; Falco P; Rosato R; Cavallo F; Giaccone L; Bringhen S; Musto P; Pregno P; Caravita T; Ciccone G; Boccadoro M | |
Efficacy of low-dose thalidomide and dexamethasone as first salvage regimen in multiple myeloma. | 2004 | Palumbo A; Bertola A; Falco P; Rosato R; Cavallo F; Giaccone L; Bringhen S; Musto P; Pregno P; Caravita T; Ciccone G; Boccadoro M. | |
Hereditary haemochromatosis | 2002 | Camaschella C; De Gobbi M; Roetto A | |
MEK-ERK pathway is expressed but not activated in high proliferating, self-renewing cord blood hematopoietic progenitors. | 2002 | BONATI A.; LUNGHI P.; GAMMAITONI L.; PINELLI S.; RIDOLO E.; DALL'AGLIO P.P.; V. PIACIBELLO; AGLIETTA M. | |
Myeloma management guidelines: a coMyeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. | 2003 | DURIE BG ;KYLE RA ;BELCH A ;BENSINGER W ;BLADE J ;BOCCADORO M ;CHILD JA ;COMENZO R ;DJULBEGOVIC B ;FANTL D ;GAHRTON G ;HAROUSSEAU JL ;HUNGRIA V ;JOSHUA D ;LUDWIG H ;MEHTA J ;MORALES AR ;MORGAN G ;NOUEL A ;OKEN M ;POWLES R ;ROODMAN D ;SAN MIGUEL J ;SHIMIZU | |
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation | 2003 | DURIE BG; KYLE RA; BELCH A; BENSINGER W; BLADE J; BOCCADORO M; CHILD JA; COMENZO R; DJULBEGOVIC B; FANTL D; GAHRTON G; HAROUSSEAU JL; HUNGRIA V; JOSHUA D; LUDWIG H; MEHTA J; MORALES AR; MORGAN G; NOUEL A; OKEN M; POWLES R; ROODMAN D; SAN MIGUEL J; SHIMIZU K; SINGHAL S; SIROHI B; SONNEVELD P; TRICOT G; VAN NESS B; SCIENTIFIC ADVISORS OF THE INTERNATIONAL MYELOMA FOUNDATION. | |
Naturally-occurring anti-G-CSF antibodies produced by human cord blood B-cell lines infected with Epstein-Barr virus | 2001 | Revoltella RP; Laricchia Robbio L; Moscato S; Vinante F; Fasciani A; Liberati AM; Reato G; Foa R | |
Simultaneous screening of known HFE and TFR2 mutations in blood donors selected for increaesd serum iron parameters. | 2002 | M De Gobbi; F Daraio; A Roetto; F Alberti; S. Bosio; MR Barilaro; C Camaschella | |
Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma | 2004 | Falco P; Bertola A; Bringhen S; Cavallo F; Boccadoro M; Palumbo A | |
The natural history of hemochromatosis type 2. | 2001 | De Gobbi M; Roetto A; Piperno A; Papanikolau G; Loukopoulos D; Lockitch G; Girelli P; Gasparini P; Cox T; Cazzola M; Camaschella C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile